13148_2019_775_MOESM1_ESM.pptx (303.53 kB)

MOESM1 of Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

Download (303.53 kB)
presentation
posted on 11.12.2019 by Cornelis van Tilburg, Till Milde, Ruth Witt, Jonas Ecker, Thomas Hielscher, Angelika Seitz, Jens-Peter Schenk, Juliane Buhl, Dennis Riehl, Michael Frühwald, Arnulf Pekrun, Claudia Rossig, Regina Wieland, Christian Flotho, Uwe Kordes, Bernd Gruhn, Thorsten Simon, Christin Linderkamp, Felix Sahm, Lenka Taylor, Angelika Freitag, Jürgen Burhenne, Kathrin Foerster, Andreas Meid, Stefan Pfister, Irini Karapanagiotou-Schenkel, Olaf Witt
Additional file 1: Figure S1. a Linear correlation Cmax (ng/mL) – Dose (mg/m2/d). b Concentration of vorinostat in plasma according to dose level.

Funding

Deutsche Kinderkrebsstiftung

History

Exports